...
首页> 外文期刊>Journal of Molecular Neuroscience >The Role of Transient Receptor Potential Vanilloid 1 (Trpv1) Receptors in Dextran Sulfate-Induced Colitis in Mice
【24h】

The Role of Transient Receptor Potential Vanilloid 1 (Trpv1) Receptors in Dextran Sulfate-Induced Colitis in Mice

机译:瞬态受体电位香草酸1(Trpv1)受体在小鼠右旋糖酐硫酸诱导的结肠炎中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to investigate the involvement of transient receptor potential vanilloid 1 (TRPV1) receptors in oral dextran sulfate sodium-induced (DSS) colitis using TRPV1 knockout mice and their wild-type C57BL/6 counterparts. DSS (2% or 5%) was administered orally ad libitum for 7 days; the controls received tap water. Animal weight, stool consistency, and blood content were scored every day to calculate the disease activity index (DAI). After sacrificing the mice on day 7, the colons were cut into three equal segments (proximal, intermediate, and distal) for histology, myeloperoxidase (MPO), and cytokine measurements. In the 2% DSS-treated group, the lack of TRPV1 receptors decreased the DAI. Each colon segment of wild-type animals showed more than two-fold increase of MPO activity and more severe histological changes compared to the knockouts. This difference was not observed in case of 5% DSS, when extremely severe inflammation occurred in both groups. IL-1β production was not altered by the absence of TRPV1. In conclusion, activation of TRPV1 channels enhances the clinical symptoms, histopathological changes, and neutrophil accumulation induced by 2% DSS. Elucidating the modulator role of TRPV1 channels in inflammatory bowel diseases may contribute to the development of novel anti-inflammatory drugs for their therapy.
机译:这项研究的目的是使用TRPV1基因敲除小鼠及其野生型C57BL / 6对应物研究瞬时受体电位类香草酸1(TRPV1)受体与口服葡聚糖硫酸钠诱导的(DSS)结肠炎的关系。随意口服DSS(2%或5%)7天;控件收到自来水。每天对动物体重,粪便稠度和血液含量进行评分,以计算疾病活动指数(DAI)。在第7天处死小鼠后,将结肠切成三个相等的部分(近端,中间和远端),用于组织学,髓过氧化物酶(MPO)和细胞因子测量。在2%DSS治疗组中,TRPV1受体的缺乏降低了DAI。与敲除相比,野生型动物的每个结肠段均显示出MPO活性增加了两倍以上,组织学变化更为严重。当两组都发生极严重的炎症时,在5%DSS的情况下未观察到这种差异。没有TRPV1不会改变IL-1β的产生。总之,激活TRPV1通道可增强2%DSS诱导的临床症状,组织病理学变化和中性粒细胞积聚。阐明TRPV1通道在炎症性肠病中的调节作用可能有助于开发新型抗炎药进行治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号